Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.05 SEK | +10.51% | +13.81% | +7.02% |
Apr. 25 | Medivir Gets Two US FDA Designations for MIV-711 | MT |
Mar. 21 | Certain Shares of Medivir AB are subject to a Lock-Up Agreement Ending on 21-MAR-2024. | CI |
Sales 2024 * | 26.75M 2.46M | Sales 2025 * | 52.18M 4.79M | Capitalization | 342M 31.4M |
---|---|---|---|---|---|
Net income 2024 * | -96M -8.82M | Net income 2025 * | -93M -8.55M | EV / Sales 2024 * | 9.23 x |
Net cash position 2024 * | 94.7M 8.7M | Net cash position 2025 * | 58M 5.33M | EV / Sales 2025 * | 5.44 x |
P/E ratio 2024 * |
-3.37
x | P/E ratio 2025 * |
-2.41
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.69% |
Latest transcript on Medivir AB
1 day | +10.51% | ||
1 week | +13.81% | ||
Current month | +11.01% | ||
1 month | +11.07% | ||
3 months | -13.01% | ||
6 months | -58.67% | ||
Current year | +7.02% |
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 22-01-23 |
Director of Finance/CFO | 50 | 19-08-11 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Director/Board Member | 68 | 18-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 3.05 | +10.51% | 355,255 |
24-04-24 | 2.76 | 0.00% | 126,115 |
24-04-23 | 2.76 | -3.16% | 431,759 |
24-04-22 | 2.85 | +6.74% | 243,245 |
24-04-19 | 2.67 | -0.37% | 129,408 |
Delayed Quote Nasdaq Stockholm, April 25, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.02% | 28.4M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- MVIR B Stock